Green Cross Cell has ranked among the top searched stocks for 4 days in the past month.


As of 2:30 PM on the 23rd, Green Cross Cell is trading at 52,300 KRW, down 9.98% from the previous day. This represents a 26.94% increase compared to December 4. Green Cross Cell is known as a developer and manufacturer of anticancer immune cell therapies.

Today, foreigners are tentatively recorded as net sellers of 3,000 shares. Over the past 5 days, individual investors have net bought 27,902 shares, while foreigners and institutions have net bought 18,276 shares and net sold 51,748 shares, respectively.


On December 22, Green Cross Cell became a market issue with a sharp rise following the approval of the phase 3 clinical trial for 'Immuncell-LC' pancreatic cancer treatment.





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing